Matches in Wikidata for { <http://www.wikidata.org/entity/Q37232522> ?p ?o ?g. }
- Q37232522 description "article científic" @default.
- Q37232522 description "article scientifique" @default.
- Q37232522 description "articolo scientifico" @default.
- Q37232522 description "artigo científico" @default.
- Q37232522 description "artículu científicu espublizáu en 2013" @default.
- Q37232522 description "bilimsel makale" @default.
- Q37232522 description "scientific article published on September 2013" @default.
- Q37232522 description "vedecký článok" @default.
- Q37232522 description "vetenskaplig artikel" @default.
- Q37232522 description "videnskabelig artikel" @default.
- Q37232522 description "vědecký článek" @default.
- Q37232522 description "wetenschappelijk artikel" @default.
- Q37232522 description "wissenschaftlicher Artikel" @default.
- Q37232522 description "наукова стаття, опублікована у вересні 2013" @default.
- Q37232522 description "научни чланак" @default.
- Q37232522 description "مقالة علمية نشرت في سبتمبر 2013" @default.
- Q37232522 name "Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis)." @default.
- Q37232522 name "Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis)." @default.
- Q37232522 name "Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration" @default.
- Q37232522 type Item @default.
- Q37232522 label "Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis)." @default.
- Q37232522 label "Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis)." @default.
- Q37232522 label "Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration" @default.
- Q37232522 prefLabel "Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis)." @default.
- Q37232522 prefLabel "Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis)." @default.
- Q37232522 prefLabel "Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration" @default.
- Q37232522 P1433 Q37232522-CE18B88B-BDFF-4DA8-9CBD-8AF8EA164F8B @default.
- Q37232522 P1476 Q37232522-F55596EE-364B-410C-B6CF-A594F1227236 @default.
- Q37232522 P2093 Q37232522-86B6A535-4AA6-4764-8C13-7AA1E3BEADD7 @default.
- Q37232522 P2093 Q37232522-8BCD8185-9C5A-4B63-88F9-01C1175431A9 @default.
- Q37232522 P2093 Q37232522-D5C7EEA2-4ADC-43FE-8A27-C5CF39962727 @default.
- Q37232522 P2093 Q37232522-D8A628C8-BD55-4875-9167-821B28F097CF @default.
- Q37232522 P2093 Q37232522-F1E050F3-8146-4EEE-951B-9FEC16278E21 @default.
- Q37232522 P2860 Q37232522-0B163D58-1E5B-406B-972D-A2F0E89DA8CF @default.
- Q37232522 P2860 Q37232522-0B657FFE-5D20-4D74-8E52-D4C11CEC94D8 @default.
- Q37232522 P2860 Q37232522-1022DEA9-5D45-4702-8BE9-EAA2C0FECE80 @default.
- Q37232522 P2860 Q37232522-12A1584A-98AF-4A1A-A4DF-A2904F87B073 @default.
- Q37232522 P2860 Q37232522-15725B9D-B792-4E53-98CF-173897354B0B @default.
- Q37232522 P2860 Q37232522-15E8F1EB-4C1B-42F8-BFAD-75D2FB2635D1 @default.
- Q37232522 P2860 Q37232522-20E4CBCB-5E35-4E41-849C-6D453CB5D112 @default.
- Q37232522 P2860 Q37232522-27D97206-CE08-422D-83C6-03FC60FF778F @default.
- Q37232522 P2860 Q37232522-290ADA9D-C742-49C1-A0CB-D9C0CE0FCFF6 @default.
- Q37232522 P2860 Q37232522-2BC6A0EA-714F-4FE5-99FF-4849D034EAFF @default.
- Q37232522 P2860 Q37232522-3047F202-1B4A-4098-82F5-AA58005EB14F @default.
- Q37232522 P2860 Q37232522-39BA8FA5-0D21-448D-AADF-359CA09ABF3D @default.
- Q37232522 P2860 Q37232522-40644046-E5B1-43B8-9D0A-EE1E4CE5713C @default.
- Q37232522 P2860 Q37232522-41C08945-B5FA-4E12-AEBA-560742ED8604 @default.
- Q37232522 P2860 Q37232522-48A8F421-13B6-416B-AB6D-C9217E06EEDC @default.
- Q37232522 P2860 Q37232522-49306992-DAEB-49B2-BB8A-8AC65706DC06 @default.
- Q37232522 P2860 Q37232522-4A129D6F-8DDF-4288-87DE-ECEB485CBF9D @default.
- Q37232522 P2860 Q37232522-4DD2B550-758E-4B8C-8A9A-6188DBFDC04D @default.
- Q37232522 P2860 Q37232522-4FBAEE26-F650-425C-9755-717941E591A6 @default.
- Q37232522 P2860 Q37232522-522F380A-A8F7-4500-81CA-FD1026266671 @default.
- Q37232522 P2860 Q37232522-5BE33977-19E5-45A2-9D4F-B2C8E5A99EF1 @default.
- Q37232522 P2860 Q37232522-5CA4A5A4-DF34-472C-97EE-B2C2B6F68CA5 @default.
- Q37232522 P2860 Q37232522-63B3091D-03B3-4F26-A6D8-A4824CB34AA6 @default.
- Q37232522 P2860 Q37232522-6A00E8BC-D793-47E6-9ECC-8AA0CEC02732 @default.
- Q37232522 P2860 Q37232522-71ADC7BA-7DA1-4C82-874A-3D06D5547A27 @default.
- Q37232522 P2860 Q37232522-742B8CA6-9FFB-4165-B002-31C30BCC5B22 @default.
- Q37232522 P2860 Q37232522-7556E184-453F-404F-8E40-28FE7562BB74 @default.
- Q37232522 P2860 Q37232522-7C666027-6C58-4262-96D6-4AE866222011 @default.
- Q37232522 P2860 Q37232522-7DBC4BFD-7140-4A82-830D-6955392DAEF2 @default.
- Q37232522 P2860 Q37232522-7F0A4DC1-5B72-4484-B790-3C9D1CE38B34 @default.
- Q37232522 P2860 Q37232522-8249656C-EAEE-46DA-9E56-4280509397A3 @default.
- Q37232522 P2860 Q37232522-85687078-D0DE-4D5E-8F0B-009BCBC8ADA5 @default.
- Q37232522 P2860 Q37232522-879E1BDA-6501-4EF8-8620-2D13BB86D136 @default.
- Q37232522 P2860 Q37232522-8958CA13-89AF-4447-9358-C7C0D5788E47 @default.
- Q37232522 P2860 Q37232522-989ED658-2044-489B-9672-A21A54CD53B7 @default.
- Q37232522 P2860 Q37232522-9E43123D-13B4-4E3D-A46D-5202AA63B54C @default.
- Q37232522 P2860 Q37232522-A145D8E5-22E4-4456-9DFB-44D5166A955C @default.
- Q37232522 P2860 Q37232522-A9A198B1-AF1A-47B9-9EAA-3857C20F17F9 @default.
- Q37232522 P2860 Q37232522-B0651DA2-55EC-4756-B889-4FFD22014CE7 @default.
- Q37232522 P2860 Q37232522-B5F44A4A-6C03-4216-886D-97527F257980 @default.
- Q37232522 P2860 Q37232522-C98FAEB9-E466-4B2D-8BC0-7EC92E301EF6 @default.
- Q37232522 P2860 Q37232522-D344C446-69A0-47F9-83E2-EF8E2FF3F50C @default.
- Q37232522 P2860 Q37232522-D4689743-4E37-46C2-8A1D-4FA9876E1A09 @default.
- Q37232522 P2860 Q37232522-DF53CE9F-BD28-49DA-90EC-474FCB4FAD12 @default.
- Q37232522 P2860 Q37232522-DF9FFDC7-514B-41EB-A648-E9F4A09BE517 @default.
- Q37232522 P2860 Q37232522-E3A14D60-7CA1-4148-B342-43405B9146C9 @default.
- Q37232522 P2860 Q37232522-FB0D0ABE-3F9F-4019-89BF-E9002613D0B1 @default.
- Q37232522 P304 Q37232522-8FFCA4F2-FC6E-4D70-AA99-C45B8FB530EC @default.
- Q37232522 P31 Q37232522-326C23D4-AECF-4C85-922F-1BCC53EB7FA5 @default.
- Q37232522 P478 Q37232522-8F2FB1C2-E42B-42C4-A285-13273010C47D @default.
- Q37232522 P577 Q37232522-7BD7BDD5-392B-493F-BBA0-E5298D13F42D @default.
- Q37232522 P698 Q37232522-4B4E88A2-8B4F-430A-88A5-30A3AC509B7B @default.
- Q37232522 P921 Q37232522-4CAF0687-B6DA-4F1D-999B-36EB7CD506F4 @default.
- Q37232522 P921 Q37232522-7193222E-8505-4C81-8328-90D7F5825971 @default.
- Q37232522 P921 Q37232522-B6742BCE-192E-4131-946E-E8D3666C0B67 @default.
- Q37232522 P932 Q37232522-53DCD98B-A722-4013-86C6-08A0B3E7FAB7 @default.
- Q37232522 P698 24167325 @default.
- Q37232522 P1433 Q26842158 @default.
- Q37232522 P1476 "Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis)." @default.
- Q37232522 P2093 "David W Hutton" @default.
- Q37232522 P2093 "Joshua D Stein" @default.
- Q37232522 P2093 "Paul P Lee" @default.
- Q37232522 P2093 "Paula Anne Newman-Casey" @default.
- Q37232522 P2093 "Tavag Mrinalini" @default.
- Q37232522 P2860 Q24245518 @default.
- Q37232522 P2860 Q24616209 @default.
- Q37232522 P2860 Q24633874 @default.